About CANSERA INC
Cansera is an AI-driven biotechnology startup focused on unlocking digital biomarkers from routine blood tests to transform cancer care. The company uses advanced machine learning to analyze entire blood samples for rare cancer-related cells, enabling earlier detection and more personalized treatments.
AI-driven analysis of digital biomarkers from routine blood testsAdvanced machine learning for rare cell detection in blood samplesCloud-based platform for processing large digital microscopy datasetsScalable and unbiased rare-cell detection without preselecting targets
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TOPIC 425 - AUTOMATED MOTION EXTRACTION AND ANALYSIS TO QUANTIFY PATIENT PERFORMANCE STATUS | Department of Health and Human Services | $2.3M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CANSERA INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.